Clinical trial
Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure With or Without HTEA
NCT02292030 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure With or Without HTEA
- Lead sponsor
- Harbin Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- October 31, 2015
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure